As of January 2026 CRISPR Therapeutics has a market cap of โฌ4.40 Billion. This makes CRISPR Therapeutics the world's 3070th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jan 11th, 2026 the market cap of CRISPR Therapeutics was reported to be: